Wednesday Novavax increased by 0.65%, ended the session at $17.03

Published: November 25 2022, 13:46 GMT+0

Wednesday Novavax increased by 0.65%, ended the session at $17.03

The US stock market is closed for the Thanksgiving holiday and resumes today. Meanwhile, here is a recap of Wednesday: generally flat but with a slight bullish bias, Novavax, Inc. ranged between $16.63 and $17.68 before closing higher at $17.03.

  • The day's trading volume totalled 3.71 million shares — slightly below the 21-day average of 4.43 million.

The US stock market is set to reconvene later today following Thanksgiving in 43 minutes time. Nasdaq went up to 11,300 for a 0.99% change. Novavax went up Wednesday and similar gains were seen throughout the Healthcare sector (up 0.732%).

The US vaccine developer is now trading 92.24% below the significant high of $217.97 it set around 11 months ago. So far in 2022, it has been doing worse than the Nasdaq by 47.45%. Novavax's market cap is currently $1.34 billion with an average daily volume of 4.43 million shares. Novavax is forecasted to generate revenues of $586.25 million and EPS of $2.21.

This rally in Novavax's share price coincided with other health care stocks as Novo Nordisk gained 2.12%, as it traded at $117.83. Medtronic was up 1.4%. Abbott Laboratories was up 1.1%.